Albion News

We are delighted to announce that Siemens AG has announced plans to acquire Process Systems Enterprise (PSE), the leading supplier of Advanced Process Modelling (APM) software and services.  PSE built a category leading industrial software business, and the excellent return is driven by a combination of strong growth (10X software revenue since AlbionVC’s initial investment) with top decile capital efficiency - little more than the £2m invested by AlbionVC raised by the company over its lifetime. The exit represents a return of c.10x for the Albion VCTs. Process Systems Enterprise (PSE), the... read more
Albion-NewHome.jpg We've recently moved offices! After 10 years in Bank, we've moved to a new office in Farringdon! Our new address is: 1 Benjamin Street, London, EC1M 5QL - our telephone number isn’t changing. read more
Will Fraser-Allen
After more than 23 years as Managing Director, and then Managing Partner of Albion Capital, Patrick Reeve has become Chairman of the business in a newly created role, with Will Fraser-Allen moving to Managing Partner, and Andrew Elder becoming Deputy Managing Partner. From April, Patrick Reeve will chair the Albion and OLIM boards and continue to be involved in directing the strategy of the business, whilst maintaining key relationships across the Albion Capital VCT range, Albion Community Power and the UCL Technology Fund. Patrick joined Close Brothers in 1989, established Close Ventures in... read more
Orchard Therapeutics, a commercial-stage biopharmaceutical company, presented their two-year follow-up data in 20 patients from the registrational trial evaluating OTL-101, aimed at treating those with adenosine deaminase deficiency (ADA-SCID). They achieved a 100% Overall Survival and 100% Event Free Survival in Patients Treated with OTL-101; compared to 88% OS and 56% EvFS with Historical HSCT Overall at 24 months ADA-SCID is a rare, life-threatening, inherited disease caused by mutations in the ADA gene. Patients with ADA-SCID are unable to fight off and frequently succumb to complications... read more
2018 2019 Securities Note
The documents relating to the Offers are now avaible on the Current Offers page read more
OLIM Charity Conference 2019
Following the success of the OLIM Charity Conference in 2018 we are delighted to invite all charity trustees and those interested in the sector to join us at this year’s event. The 2018 OLIM Charity Conference attracted over 150 Trustees from a wide variety of charities and the feedback on the whole event was very positive. 2019 OLIM Charity Conference – ‘Charity Trustees in a Changing World’ Date: Thursday 6 June 2019 Venue: The RAC, 89 Pall Mall, St James’s, London SW1Y 5HS Time 10:00 – 14:30 If you would like to attend the next event, or need more information about OLIM, please email us at... read more
FT Adviser
Will Fraser-Allen, deputy managing partner of Albion writes in FT Adviser To read the full article please click here read more
G Network
G.Network, Albion Capital and Cube IM are pleased to announce that G.Network and Albion have closed an agreement with Cube Infrastructure Fund II, whereby Cube II is providing an initial GBP60 million of additional funding to G.Network. G.Network is a fast-growing full fibre local access connectivity provider focused on London. G.Network is building and operating new Fibre to the Premises (FTTP) infrastructure across the capital to provide affordable ultra-fast fibre connectivity to businesses and residents. G.Network’s full fibre local access solutions are bridging the gap between old... read more
The fundraising is expected to target £6 million for each of the six Albion VCTs: Albion Venture Capital Trust PLC, Albion Development VCT PLC, Albion Enterprise VCT PLC, Albion Technology & General VCT PLC, Crown Place VCT PLC and Kings Arms Yard VCT PLC. The Albion VCTs’ combined portfolios have a value of approximately £400 million*, diversified across approximately 60 businesses. The planned top up offers reflect Albion Capital’s confidence in an exciting pipeline of investment opportunities in sectors with long-term growth potential. Over the last five years the Albion VCTs have... read more
Growth Investor of the Year Award
Albion is delighted to have won the award for GROWTH INVESTOR OF THE YEAR 2018   Growth Investor of the Year Award   This is the highest accolade for investment providers, and recognises those demonstrating the best investment performance, the best impact on an investee company, the most innovation in product development, and the most engagement in adviser outreach. The Finalists were: Albion Capital Calculus Capital Deepbridge Capital Mercia Fund Managers MMC Ventures Octopus Investments Oxford Capital Seneca Congratulations to everyone. read more

Pages